+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Hemostats Market by Type (Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application - Forecast 2024-2030- Product Image
Global Hemostats Market by Type (Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application - Forecast 2024-2030- Product Image
Sale

Global Hemostats Market by Type (Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5847077
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Hemostats Market size was estimated at USD 3.23 billion in 2023, USD 3.42 billion in 2024, and is expected to grow at a CAGR of 5.65% to reach USD 4.75 billion by 2030.

The hemostats are a range of medical devices and products designed to control, prevent, and stop bleeding during surgical procedures and traumatic injuries. These devices play an important role in managing blood loss and facilitate proper tissue healing while reducing the risk of complications. Hemostats have applications in numerous surgical specialties, including cardiovascular surgery, general surgery, orthopedic surgery, neurosurgery, gynecologic surgery, and dental surgery. The growing occurrence of chronic diseases among an aging population drives the demand for surgeries that necessitate effective blood loss management solutions, consequently expanding the utilization of diverse hemostatic agents.

Additionally, increasing inclination toward minimally invasive procedures with rising investments by government bodies and healthcare organizations to improve surgical infrastructure is raising the usage of hemostats. High R&D costs associated with developing breakthrough products and a high risk of contamination with hemostats hamper market growth. The increasing development of biologically compatible hemostats by market vendors that minimize adverse effects while providing effective bleeding control is expected to create opportunities for market growth.

Regional Insights

The growing number of surgical procedures with the rising availability of advanced healthcare facilities, especially across the U.S., Canada, and Brazil, are expanding the growth of the hemostats market in the Americas. According to the American Society of Plastic Surgeons, in 2022, a total of 1,017,003 reconstructive surgeries were performed, necessitating the use of hemostats. The emerging trend of medical tourism across Canada, Dubai, Singapore, Japan, and the UK is expanding the number of minimally invasive surgical procedures, thereby creating a platform for the hemostats market. According to the Medical Tourism Index survey (MTA), Canada is one of the preferred destinations, attracting around 14 million Americans from other nations.

Ongoing advancements in healthcare infrastructure and technologies across European countries, with constant support from regulatory bodies such as the European Medicines Agency (EMA) on expanding the manufacturing of medical devices and healthcare infrastructure, are bolstering the European market. The Middle East & Africa region presents promising growth opportunities due to increasing healthcare expenditure and government initiatives towards modernizing healthcare infrastructure. Countries, including Saudi Arabia, the United Arab Emirates, and South Africa, are witnessing a surge in the need for effective hemostatic solutions with the rising number of surgical interventions. Moreover, increased government funding to expand the manufacturing of medical devices domestically across India, Australia, China, and Japan and increased awareness associated with minimally invasive surgeries are expected to bolster market growth in Asia-Pacific.

Market Trends by Segment

  • Type: Expanding the use of combination hemostats owing to their enhanced effectiveness in minimizing bleeding
  • Formulation: Growing potential of powder hemostats for controlling and preventing bleeding during surgical intervention
  • Application: Significant role of hemostats in cardiovascular surgeries to prevent blood loss and ensure successful outcomes

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures

Teleflex Incorporated received clearance from the U.S. Food and Drug Administration (FDA) for the QuikClot Control+ Hemostatic Device. This device is now approved for use in cardiac surgical procedures to address mild and moderate bleeding, as well as bone surface bleeding after a sternotomy.

Baxter Launches PERCLOT Absorbable Hemostatic Powder

Baxter International Inc. introduced PERCLOT Absorbable Hemostatic Powder in the U.S., a passive hemostatic powder designed for patients with intact coagulation. PERCLOT's granules effectively absorb water, forming a gelled adhesive matrix that acts as a mechanical barrier against further bleeding. This process promotes the accumulation of platelets, red blood cells, and coagulation proteins, aiding in the hemostatic process.

Artivion Gains FDA Approval for PerClot, Starts Transfer to Baxter

Artivion, Inc. has received FDA premarket application approval for its absorbable hemostatic system, PerClot. In July 2021, Baxter acquired full ownership of PerClot through a sale agreement. The FDA approval of PerClot, Artivion represents a significant step ahead in optimizing patient care by addressing intraoperative bleeding.

Key Company Profiles

The report delves into recent significant developments in the Hemostats Market, highlighting leading vendors and their innovative profiles. These include A.R. Medicom, Inc., ACTEON Group, Advamedica Inc., Advanced Medical Solutions Group PLC, Advin Health Care, Aegis Lifesciences Private Limited, Argon Medical Devices, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Betatech Medical, Convatec Group PLC, Cook Group Incorporated, Cortis Medtech Pvt Ltd, Cotran Corporation, Dolphin Sutures by Futura Surgicare Pvt. Ltd., Dynarex Corporation, Gelita AG, Hangzhou Singclean Medical Products Co.,Ltd., Healthium Medtech Ltd, Hemostasis, LLC, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Medcura, Inc., Medline Industries, LP, Medprin Biotech GmbH, Medtronic PLC, Meril Life Sciences Pvt. Ltd., Olympus Corporation, Pfizer Inc., Rousselot BV by Darling Ingredients International Holding B.V., Royal DSM, Shilpa Medicare Limited, Stapleline Medizintechnik GmbH, Stryker Corporation, SYMATESE, Teleflex Incorporated, Terumo Corporation, Zhejiang Perfectseal New Material Technology Co., Ltd., and Zimmer Biomet Holdings, Inc.

This research report offers invaluable insights into various crucial aspects of the Hemostats Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic disorders with increasing need for surgical interventions
5.1.1.2. Growing inclination toward minimally invasive surgeries
5.1.2. Restraints
5.1.2.1. Rising incidences of product recalls
5.1.3. Opportunities
5.1.3.1. Rise of biopolymer-based disposable hemostats
5.1.3.2. Integration of nanotechnology to create more efficient and targeted hemostats
5.1.4. Challenges
5.1.4.1. Risk of infection and cross contamination associated with the use of hemostats tools and reagents
5.2. Market Segmentation Analysis
5.2.1. Type: Expanding the use of combination hemostats owing to their enhanced effectiveness in minimizing bleeding
5.2.2. Formulation: Growing potential of powder hemostats for controlling and preventing bleeding during surgical intervention
5.2.3. Application: Significant role of hemostats in cardiovascular surgeries to prevent blood loss and ensure successful outcomes
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Hemostats Market, by Type
6.1. Introduction
6.2. Collagen-Based Hemostats
6.3. Combination Hemostats
6.4. Gelatin-Based Hemostats
6.5. Oxidized Regenerated Cellulose-Based Hemostats
6.6. Thrombin-Based Hemostats
7. Hemostats Market, by Formulation
7.1. Introduction
7.2. Matrix & Gel Hemostats
7.3. Powder Hemostats
7.4. Sheet & Pad Hemostats
7.5. Sponge Hemostats
8. Hemostats Market, by Application
8.1. Introduction
8.2. Cardiovascular Surgery
8.3. General Surgery
8.4. Gynecological Surgery
8.5. Neurological Surgery
8.6. Orthopedic Surgery
8.7. Reconstructive Surgery
9. Americas Hemostats Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Hemostats Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Hemostats Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures
12.3.2. Baxter Launches PERCLOT Absorbable Hemostatic Powder
12.3.3. Artivion Gains FDA Approval for PerClot, Starts Transfer to Baxter
12.3.4. Olympus Europa SE & Co. KG Expands Endoclot Partnership with Endoclot to Launch Hemostatic Agents
12.3.5. Darling Ingredients Completes Acquisition of Brazilian Gelatin and Collagen Producer Gelnex
12.3.6. Chitosan-Based Hemostat For Controlling Severe Surgical Bleeding Gets FDA Clearance
12.3.7. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
12.3.8. Medcura, Inc. Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
12.3.9. Medtronic plc Nexpowder Endoscopic Hemostasis System Receives U.S. FDA Clearance
12.3.10. Hemostasis LLC Closes Acquisition of Fiagon Medical Technologies
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. HEMOSTATS MARKET RESEARCH PROCESS
FIGURE 2. HEMOSTATS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HEMOSTATS MARKET DYNAMICS
FIGURE 7. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. HEMOSTATS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL HEMOSTATS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL HEMOSTATS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL HEMOSTATS MARKET SIZE, BY COLLAGEN-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL HEMOSTATS MARKET SIZE, BY COLLAGEN-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL HEMOSTATS MARKET SIZE, BY COMBINATION HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL HEMOSTATS MARKET SIZE, BY COMBINATION HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL HEMOSTATS MARKET SIZE, BY GELATIN-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL HEMOSTATS MARKET SIZE, BY GELATIN-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL HEMOSTATS MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL HEMOSTATS MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL HEMOSTATS MARKET SIZE, BY THROMBIN-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL HEMOSTATS MARKET SIZE, BY THROMBIN-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL HEMOSTATS MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL HEMOSTATS MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL HEMOSTATS MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL HEMOSTATS MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL HEMOSTATS MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL HEMOSTATS MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL HEMOSTATS MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL HEMOSTATS MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL HEMOSTATS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL HEMOSTATS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL HEMOSTATS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL HEMOSTATS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL HEMOSTATS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL HEMOSTATS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. CANADA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 64. CANADA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 65. CANADA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 66. CANADA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 67. CANADA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 68. CANADA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 69. MEXICO HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 70. MEXICO HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 71. MEXICO HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 72. MEXICO HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 73. MEXICO HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. MEXICO HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. UNITED STATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 76. UNITED STATES HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 77. UNITED STATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 78. UNITED STATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 84. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 86. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 90. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 91. AUSTRALIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 92. AUSTRALIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 93. AUSTRALIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 94. AUSTRALIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 95. AUSTRALIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. AUSTRALIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. CHINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 98. CHINA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 99. CHINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 100. CHINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 101. CHINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. CHINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. INDIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 104. INDIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 105. INDIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 106. INDIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 107. INDIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. INDIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. INDONESIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 110. INDONESIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111. INDONESIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 112. INDONESIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 113. INDONESIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. INDONESIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. JAPAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 116. JAPAN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 117. JAPAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 118. JAPAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 119. JAPAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. JAPAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. MALAYSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. MALAYSIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. MALAYSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 124. MALAYSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 125. MALAYSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. MALAYSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. PHILIPPINES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 128. PHILIPPINES HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 129. PHILIPPINES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 130. PHILIPPINES HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 131. PHILIPPINES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. PHILIPPINES HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. SINGAPORE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 134. SINGAPORE HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 135. SINGAPORE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 136. SINGAPORE HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 137. SINGAPORE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. SINGAPORE HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. SOUTH KOREA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 140. SOUTH KOREA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 141. SOUTH KOREA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 142. SOUTH KOREA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 143. SOUTH KOREA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. SOUTH KOREA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. TAIWAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 146. TAIWAN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 147. TAIWAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 148. TAIWAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 149. TAIWAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. TAIWAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. THAILAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 152. THAILAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 153. THAILAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 154. THAILAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 155. THAILAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. THAILAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. VIETNAM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. VIETNAM HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. VIETNAM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 160. VIETNAM HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 161. VIETNAM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. VIETNAM HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 171. DENMARK HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 172. DENMARK HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 173. DENMARK HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 174. DENMARK HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 175. DENMARK HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. DENMARK HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. EGYPT HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 178. EGYPT HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 179. EGYPT HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 180. EGYPT HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 181. EGYPT HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. EGYPT HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. FINLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 184. FINLAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 185. FINLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 186. FINLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 187. FINLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. FINLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. FRANCE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 190. FRANCE HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 191. FRANCE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 192. FRANCE HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 193. FRANCE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. FRANCE HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. GERMANY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 196. GERMANY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 197. GERMANY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 198. GERMANY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 199. GERMANY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. GERMANY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. ISRAEL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 202. ISRAEL HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 203. ISRAEL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 204. ISRAEL HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 205. ISRAEL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. ISRAEL HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. ITALY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 208. ITALY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 209. ITALY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 210. ITALY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 211. ITALY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. ITALY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. NETHERLANDS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 214. NETHERLANDS HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 215. NETHERLANDS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 216. NETHERLANDS HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 217. NETHERLANDS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. NETHERLANDS HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. NIGERIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 220. NIGERIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 221. NIGERIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 222. NIGERIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 223. NIGERIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. NIGERIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. NORWAY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 226. NORWAY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 227. NORWAY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 228. NORWAY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 229. NORWAY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. NORWAY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. POLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 232. POLAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233. POLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 234. POLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 235. POLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. POLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. QATAR HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 238. QATAR HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 239. QATAR HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 240. QATAR HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 241. QATAR HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. QATAR HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. RUSSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 244. RUSSIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 245. RUSSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 246. RUSSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 247. RUSSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. RUSSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 250. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 252. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 256. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 258. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. SPAIN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 262. SPAIN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 263. SPAIN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 264. SPAIN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 265. SPAIN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. SPAIN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. SWEDEN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 268. SWEDEN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 269. SWEDEN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 270. SWEDEN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 271. SWEDEN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. SWEDEN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. SWITZERLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 274. SWITZERLAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 275. SWITZERLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 276. SWITZERLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 277. SWITZERLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. SWITZERLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. TURKEY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 280. TURKEY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 281. TURKEY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 282. TURKEY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 283. TURKEY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 284. TURKEY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 292. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 294. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 296. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 297. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 298. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • A.R. Medicom, Inc.
  • ACTEON Group
  • Advamedica Inc.
  • Advanced Medical Solutions Group PLC
  • Advin Health Care
  • Aegis Lifesciences Private Limited
  • Argon Medical Devices
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Betatech Medical
  • Convatec Group PLC
  • Cook Group Incorporated
  • Cortis Medtech Pvt Ltd
  • Cotran Corporation
  • Dolphin Sutures by Futura Surgicare Pvt. Ltd.
  • Dynarex Corporation
  • Gelita AG
  • Hangzhou Singclean Medical Products Co.,Ltd.
  • Healthium Medtech Ltd
  • Hemostasis, LLC
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Medcura, Inc.
  • Medline Industries, LP
  • Medprin Biotech GmbH
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • Olympus Corporation
  • Pfizer Inc.
  • Rousselot BV by Darling Ingredients International Holding B.V.
  • Royal DSM
  • Shilpa Medicare Limited
  • Stapleline Medizintechnik GmbH
  • Stryker Corporation
  • SYMATESE
  • Teleflex Incorporated
  • Terumo Corporation
  • Zhejiang Perfectseal New Material Technology Co., Ltd.
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.42 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.75 Billion
Compound Annual Growth Rate5.6%
Regions CoveredGlobal
No. of Companies Mentioned40

Related Topics

Related Reports

Global Topical Hemostat Market by Product (Collagen-Based Topical Hemostats, Combination Topical Hemostats, Gelatin-Based Topical Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application, End-Use - Forecast 2024-2030 - Product Image

Global Topical Hemostat Market by Product (Collagen-Based Topical Hemostats, Combination Topical Hemostats, Gelatin-Based Topical Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application, End-Use - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From
Global Hemostats Market Size, Share & Trends Analysis Report by Type (Oxidized Regenerated Cellulose Based Hemostats), Formulation (Matrix & Gel Hemostats), Application (General Surgery), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Hemostats Market Size, Share & Trends Analysis Report by Type (Oxidized Regenerated Cellulose Based Hemostats), Formulation (Matrix & Gel Hemostats), Application (General Surgery), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 130 Pages
  • Global
From
Global Hemostats Market by Type (Thrombin, Oxidized Regenerated Cellulose, Combination, Gelatin, Collagen), Formulation (Matrix & Gel, Sheet & Pad, Sponge, Powder), Application (Orthopedic, Neurological, Cardiovascular Surgery), Region - Forecast to 2028 - Product Image

Global Hemostats Market by Type (Thrombin, Oxidized Regenerated Cellulose, Combination, Gelatin, Collagen), Formulation (Matrix & Gel, Sheet & Pad, Sponge, Powder), Application (Orthopedic, Neurological, Cardiovascular Surgery), Region - Forecast to 2028

  • Report
  • 223 Pages
  • Global
From
Hemostats Market Report by Product, Application, Formulation, and Region 2024-2032 - Product Image

Hemostats Market Report by Product, Application, Formulation, and Region 2024-2032

  • Report
  • 140 Pages
  • Global
From
Global Hemostats & Tissue Sealants Market by Product Type (Hemostats, Tissue sealants), Application (Burn & Trauma Cases, Cardiovascular, General Surgeries), End User - Forecast 2024-2030 - Product Image

Global Hemostats & Tissue Sealants Market by Product Type (Hemostats, Tissue sealants), Application (Burn & Trauma Cases, Cardiovascular, General Surgeries), End User - Forecast 2024-2030

  • Report
  • 192 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.